SARDAEN is currently hovering around a high-conviction Decider Level of 516.50–520.00. This narrow range is serving as the ultimate "line in the sand" for the stock's next major trend. After a period of underperformance (-10% over the last year), the price is testing this threshold to determine if a reversal is in play.
As of today, the stock closed at 512.70 (up 5.5%), showing a strong intraday recovery and putting it within striking distance of the decider zone.
Bullish Continuation (Target: 538):
Trigger: A sustained trade above 520.
Logic: Reclaiming 520 would invalidate the recent bearish trend and likely trigger a short-covering rally toward the next resistance pocket.
Target: 538 (Previous swing high/pivot point).
Bearish Rejection (Target: 497):
Trigger: Failure to clear 520 and a subsequent trade below 516.50.
Logic: If the decider zone acts as supply, the stock is likely to fall back to its recent consolidation floor.
Target: 497 (Testing the 52-week low support zone).
As of today, the stock closed at 512.70 (up 5.5%), showing a strong intraday recovery and putting it within striking distance of the decider zone.
Bullish Continuation (Target: 538):
Trigger: A sustained trade above 520.
Logic: Reclaiming 520 would invalidate the recent bearish trend and likely trigger a short-covering rally toward the next resistance pocket.
Target: 538 (Previous swing high/pivot point).
Bearish Rejection (Target: 497):
Trigger: Failure to clear 520 and a subsequent trade below 516.50.
Logic: If the decider zone acts as supply, the stock is likely to fall back to its recent consolidation floor.
Target: 497 (Testing the 52-week low support zone).
Trade closed: target reached
This was wonderful, touched lower level of zone and hit target 497
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.